All Infection Prevention & Control articles – Page 2
-
NewsAnti-HIV antibody clinical trials offer clues to prevent viral escape and resistance
The broadly neutralizing antibody VRC01 has been thoroughly vetted as a potential prophylactic that could prevent people from becoming infected with HIV. A new analysis of data shows that the antibody initially provides strong protection, but that some strains of the virus can still cause breakthrough infections after treatment has stopped.
-
NewsCRISPR map reveals 6,500 genetic interactions in tuberculosis bacteria
Researchers have created the most detailed map yet of how essential genes interact in Mycobacterium tuberculosis. By uncovering nearly 6,500 genetic relationships, the study reveals hidden gene functions and points to new ways of identifying drug targets and more effective antibiotic combinations.
-
NewsToothbrush produces electricity to battle plaque-making bacteria
A new toothbrush generates electricity through bristle movement to wage war on plaque-producing pathogens. The invention successfully reduced cavity- and periodontitis-causing bacteria better than regular mechanical brushing in the mouths of 115 volunteers over 3 months.
-
NewsStudy identifies fetal bovine serum in vaccines as key risk factor for spinal deformities in farmed Atlantic salmon
New peer-reviewed research demonstrates a strong association between residual fetal bovine serum in oil-adjuvanted vaccines and the prevalence of “cross-stitch” vertebrae, a condition linked to significant growth reduction.
-
NewsOxford-developed vaccine recommended to enter pivotal trial against deadly Bundibugyo virus
A vaccine candidate developed by scientists at the University of Oxford has been recommended to enter a pivotal Phase 2/3 clinical trial in the Democratic Republic of the Congo (DRC), in a significant step towards tackling Bundibugyo virus, a potentially deadly pathogen for which no vaccine is currently approved.
-
NewsHow a gut virus hijacks mucus production to slip past the body’s protective barrier
A recent study reveals how astroviruses use goblet cells as an escape route from the small intestines to evade host immunity and enhance spread and transmission, presenting a new path for treating pediatric diarrhea.
-
NewsLow-level lead exposure linked to higher strep throat risk in children
Even relatively low levels of lead exposure may be linked to a higher risk of strep throat in children. In a study of more than 13,000 children, those with blood lead levels below current public health action thresholds still had substantially higher odds of a strep diagnosis.
-
NewsResearchers harness the microbiome to prevent deadly bloodstream infections
Researchers have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens.
-
NewsNasal microbiome: When neighboring bacteria help pathogens thrive
Whether Staphylococcus aureus can establish itself in our noses also depends on the bacteria living alongside it. These microbial neighbors can either promote or inhibit the pathogen. Key factors include which nutrients the community consumes or releases and the metabolic capabilities of the particular S. aureus strain.
-
NewsHorizon Awards 2026: Professor James Ebdon named as winner of John Snow Prize
Environmental microbiologist Professor James Ebdon, from the University of Brighton, UK, has been named as the winner of the John Snow Public Health Innovation Prize, which recognises outstanding achievements in applied microbiology that deliver measurable improvements in public health and environmental health outcomes.
-
NewsWho actually benefits from H. pylori treatment? A genetic score can tell before the first pill
In two Chinese randomized trials, a genetic score built from 11 variants identified people whose gastric cancer risk fell 56%–80% after Helicobacter pylori eradication — cutting the number needed to treat from 112 to 43.
-
NewsAn eight-year study of epidemiology and disease burden of child enterovirus in China
An eight-year multicenter study from China shows that while most hospitalized enterovirus cases occur in very young children and have favorable outcomes, a small number develop serious complications involving the brain, heart and other organs, leading to substantially greater use of hospital resources.
-
NewsHalf of long COVID patients see meaningful symptom improvement within three years
A prospective cohort study found that about half of people living with long COVID a year after their initial COVID-19 infection experienced a meaningful symptom improvement within three years, whereas a quarter experienced a complete remission.
-
NewsAdvancing toward a functional cure for chronic hepatitis B: China’s evolving role
China has made progress in preventing HBV infections through infant vaccination and measures to prevent mother-to-child transmission. However, approximately 75 million people in the country still live with chronic HBV infection. A new review examine China’s contribution to developing treatments for chronic hepatitis B.
-
NewsHerpes infection detailed in human skin model
Researchers have traced step by step how herpes simplex virus 1 infects the multiple layers of skin cells. Using human hair-bearing skin organoids as a model, the researchers mapped how the virus spreads and which signaling molecules cells release to their neighbors upon being infected.
-
NewsA shield for the fungus, fuel for the immune response
In an earlier study, researchers demonstrated that albumin, the most abundant protein in human blood, can enhance the pathogenic properties of Candida albicans. It has now been revealed that this protein can also trigger an excessive inflammatory response.
-
News$3.67m NIH grant targets alphaviruses and their neurological damage
A $3.67 million NIH-funded project is developing antiviral compounds that could block alphavirus replication and help protect the brain from severe infection. Researchers will also use blood-brain-barrier-on-a-chip models to test whether early treatment can reduce neurological damage.
-
NewsAmino acid boosts last-resort antibiotic’s effectiveness
Colistin is a powerful, last-resort antibiotic for bacterial infections, but the number of colistin-resistant infections is growing. New research suggests that adding L-arginine, an amino acid, to colistin may overcome resistance. Lab and mouse studies show promising results, but more tests are needed before the strategy can help people.
-
NewsReview explores hepatitis B surface antigen clearance rate in chronic hepatitis B virus infection treated with pegylated interferon-α
Researchers review the hepatitis B surface antigen clearance rate with pegylated interferon-α therapy in different chronic hepatitis B infection populations.
-
NewsNew report calls for stronger One Health systems as climate risks grow
Climate change and shrinking global health budgets are increasing the pressure on systems designed to prevent diseases that spread between animals and people. A new report calls for stronger One Health surveillance, more investment in frontline veterinary and environmental services, and greater emphasis on preventing spillover before outbreaks begin.